(Total Views: 456)
Posted On: 11/13/2020 1:55:47 PM
Post# of 70
$DRRX News Article - DURECT Corporation Announces Additional Safety Data and Efficacy Signals from Phase 1b Clinical Trial of DUR-928 in NASH Patients at The Liver Meeting Digital Experience(TM) 2020 https://marketwirenews.com/news-releases/dure...31832.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
